Provided by Tiger Trade Technology Pte. Ltd.

Provident

23.57
-0.1400-0.59%
Pre-market: 23.44-0.1348-0.57%04:06 EDT
Volume:887.39K
Turnover:20.98M
Market Cap:3.08B
PE:9.83
High:23.87
Open:23.70
Low:23.57
Close:23.71
52wk High:25.49
52wk Low:17.69
Shares:130.62M
Float Shares:126.13M
Volume Ratio:1.13
T/O Rate:0.70%
Dividend:0.96
Dividend Rate:4.07%
EPS(TTM):2.40
EPS(LYR):2.23
ROE:11.14%
ROA:1.25%
PB:1.06
PE(LYR):10.56

Loading ...

George Lista, Pres/CEO Prov Protection Plus, sells 2,556 Provident Financial shares for $57,254.4

Reuters
·
May 13

Press Release: Immatics Announces First Quarter 2026 Financial Results and Business Update

Dow Jones
·
May 12

Turaco Gold Identifies Gold Mineralization at Ivory Coast Project

MT Newswires Live
·
May 12

TMC and Allseas Sign Commercial Agreement for the First Offshore Nodule Recovery Operation

GlobeNewswire
·
May 11

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

GlobeNewswire
·
May 11

Provident Financial Q1 FY26 net income rises 24.1% to $79.4 million; net interest margin widens 6 bps to 3.4%

Reuters
·
May 09

Press Release: Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates

Dow Jones
·
May 08

Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 07

Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

GlobeNewswire
·
May 07

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire
·
May 06

Press Release: Theriva(TM) Biologics Reports First Quarter 2026 Operational Highlights and Financial Results

Dow Jones
·
May 06

Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates

GlobeNewswire
·
May 06

Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

GlobeNewswire
·
May 05

Press Release: Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update

Dow Jones
·
May 05

Brightstar hits high-grade gold as Sandstone drilling drives resource upgrade and PFS

TIPRANKS
·
May 05

Does Provident’s Strong Q1 Beat Driven by Insurance and Lending Shift the Bull Case for PFS?

Simply Wall St.
·
May 05

Is It Too Late To Consider Provident Financial Services (PFS) After Strong Regional Bank Rebound?

Simply Wall St.
·
May 03

Provident Fincl Services Is Maintained at Outperform by Keefe, Bruyette & Woods

Dow Jones
·
May 01

Press Release: ExGen Signs Purchase Agreement to Acquire Lithium Properties in Nevada

Dow Jones
·
May 01

Press Release: Provident Financial Services, Inc. Declares Quarterly Cash Dividend

Dow Jones
·
May 01